de Araujo Elvin D, Manaswiyoungkul Pimyupa, Israelian Johan, Park Jisung, Yuen Karen, Farhangi Shiva, Berger-Becvar Angelika, Abu-Jazar Lubna, Gunning Patrick T
Department of Chemical and Physical Sciences, University of Toronto Mississauga, 3359 Mississauga Rd N., Mississauga, Ontario L5L 1C6, Canada; Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, Ontario M5S 3H6, Canada.
Department of Chemical and Physical Sciences, University of Toronto Mississauga, 3359 Mississauga Rd N., Mississauga, Ontario L5L 1C6, Canada; Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, Ontario M5S 3H6, Canada.
J Pharm Biomed Anal. 2017 Sep 5;143:159-167. doi: 10.1016/j.jpba.2017.04.052. Epub 2017 May 1.
The development of STAT protein-specific inhibitors has been the focus of a number of drug discovery programs. STAT activation occurs through phosphorylation at the STAT SH2 domain, resulting in dimerization, translocation to the nucleus, and transcription of proliferative genes. Due to the functional significance of the SH2 domain in mediating multiple components of the STAT signalling cascade, many libraries of inhibitors have been designed to target the SH2 domain. This has triggered the requirement for effective high-throughput screening platforms for analyzing binding by larger chemical libraries to STAT proteins. Herein, we present strategies for the development of a high-throughput thermal denaturation-based assay for identifying STAT inhibitors as well as high-yielding recombinant expression and purification of untagged STAT1, STAT3, and STAT5 proteins. This assay reports changes in the fluorescence of a labelled peptide bound to the STAT protein as a function of increasing temperature. STAT inhibitors which displace the labelled peptide elicit a change in the melt profile, which is quantitatively determined as a change in the area under the curve. This assay offers an alternative, but complimentary, high-throughput screening strategy for identifying new inhibitors of STAT proteins as well as characterizing further, the mode of inhibition by existing libraries of compounds.
STAT蛋白特异性抑制剂的研发一直是众多药物发现项目的重点。STAT的激活通过其SH2结构域的磷酸化发生,导致二聚化、转位至细胞核以及增殖基因的转录。由于SH2结构域在介导STAT信号级联反应的多个组分中具有功能重要性,许多抑制剂文库已被设计用于靶向SH2结构域。这引发了对有效高通量筛选平台的需求,以分析更大化学文库与STAT蛋白的结合情况。在此,我们展示了用于开发基于高通量热变性分析以鉴定STAT抑制剂的策略,以及用于无标签STAT1、STAT3和STAT5蛋白的高产重组表达和纯化的策略。该分析报告与STAT蛋白结合的标记肽的荧光变化随温度升高的函数关系。取代标记肽的STAT抑制剂会引起熔解曲线的变化,该变化通过曲线下面积的变化进行定量测定。该分析为鉴定STAT蛋白的新抑制剂以及进一步表征现有化合物文库的抑制模式提供了一种替代但互补的高通量筛选策略。